XML 15 R5.htm IDEA: XBRL DOCUMENT v3.23.2
Consolidated Statements of Stockholders’ Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock Class A
Common Stock Class B
Common Stock
Common Stock Class A
Common Stock
Common Stock Class B
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2021       170,625,994 9,842,105      
Balance at Dec. 31, 2021 $ 11,031,466     $ 168 $ 12 $ 13,169,118 $ (18,141) $ (2,119,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (221,627)             (221,627)
Exercises of vested stock options (in shares)       180,643 193,889      
Exercises of vested stock options 11,727         11,727    
Vesting of restricted stock units (in shares)       877,089        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (5,804)        
Value of equity awards withheld for tax liability (1,065)         (1,065)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       215,389 (215,389)      
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 4,232         4,232    
Shares returned from escrow (in shares)       (152,239)        
Shares returned from escrow (387)         (387)    
Unrealized gain (loss) on marketable securities (62,826)           (62,826)  
Foreign currency translation (165)           (165)  
Net change in market value of effective foreign currency forward exchange contracts (3,852)           (3,852)  
Stock-based compensation 159,930         159,930    
Ending balance (in shares) at Mar. 31, 2022       171,763,174 9,820,605      
Balance at Mar. 31, 2022 10,917,433     $ 169 $ 12 13,343,554 (84,984) (2,341,318)
Beginning balance (in shares) at Dec. 31, 2021       170,625,994 9,842,105      
Balance at Dec. 31, 2021 11,031,466     $ 168 $ 12 13,169,118 (18,141) (2,119,691)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (544,396)              
Unrealized gain (loss) on marketable securities (81,848)              
Foreign currency translation (2,454)              
Net change in market value of effective foreign currency forward exchange contracts (14,958)              
Share of other comprehensive income from equity method investment 0              
Ending balance (in shares) at Jun. 30, 2022       173,271,942 9,817,605      
Balance at Jun. 30, 2022 10,841,995     $ 171 $ 12 13,623,300 (117,401) (2,664,087)
Beginning balance (in shares) at Mar. 31, 2022       171,763,174 9,820,605      
Balance at Mar. 31, 2022 10,917,433     $ 169 $ 12 13,343,554 (84,984) (2,341,318)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (322,769)             (322,769)
Exercises of vested stock options (in shares)       98,111 77,732      
Exercises of vested stock options 5,649         5,649    
Vesting of restricted stock units (in shares)       1,049,640        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (38)        
Value of equity awards withheld for tax liability (4)         (4)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       80,732 (80,732)      
Shares issued under ESPP (in shares)       258,221        
Shares issued under ESPP 24,318     $ 1   24,317    
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 2,373         2,373    
Unrealized gain (loss) on marketable securities (19,022)           (19,022)  
Foreign currency translation (2,289)           (2,289)  
Net change in market value of effective foreign currency forward exchange contracts (11,106)           (11,106)  
Share of other comprehensive income from equity method investment 0              
Stock-based compensation 247,412         247,412    
Ending balance (in shares) at Jun. 30, 2022       173,271,942 9,817,605      
Balance at Jun. 30, 2022 10,841,995     $ 171 $ 12 13,623,300 (117,401) (2,664,087)
Beginning balance (in shares) at Dec. 31, 2022   176,358,104 9,617,605 176,358,104 9,617,605      
Balance at Dec. 31, 2022 10,559,042     $ 174 $ 12 14,055,853 (121,161) (3,375,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (342,139)             (342,139)
Exercises of vested stock options (in shares)       66,968 97,199      
Exercises of vested stock options 3,264         3,264    
Vesting of restricted stock units (in shares)       1,516,634        
Vesting of restricted stock units 0     $ 2   (2)    
Value of equity awards withheld for tax liability (in shares)       (36,965)        
Value of equity awards withheld for tax liability (2,456)         (2,456)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       97,199 (97,199)      
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 1,599         1,599    
Unrealized gain (loss) on marketable securities 30,750           30,750  
Repurchases of shares of Class A common stock including related costs (in shares)       (1,902,124)        
Repurchases of shares of Class A common stock including related costs (124,992)     $ (2)       (124,990)
Foreign currency translation 483           483  
Net change in market value of effective foreign currency forward exchange contracts 3,335           3,335  
Share of other comprehensive income from equity method investment 14,648           14,648  
Stock-based compensation 164,999         164,999    
Stock-based compensation - restructuring 10,333         10,333    
Ending balance (in shares) at Mar. 31, 2023       176,121,918 9,617,605      
Balance at Mar. 31, 2023 10,318,866     $ 174 $ 12 14,233,590 (71,945) (3,842,965)
Beginning balance (in shares) at Dec. 31, 2022   176,358,104 9,617,605 176,358,104 9,617,605      
Balance at Dec. 31, 2022 10,559,042     $ 174 $ 12 14,055,853 (121,161) (3,375,836)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (508,326)              
Unrealized gain (loss) on marketable securities $ 39,355              
Repurchases of shares of Class A common stock including related costs (in shares) (8,300,000)              
Foreign currency translation $ 569              
Net change in market value of effective foreign currency forward exchange contracts 1,168              
Share of other comprehensive income from equity method investment 19,794              
Stock-based compensation - restructuring 10,600              
Ending balance (in shares) at Jun. 30, 2023   181,174,616 0 181,174,616 0      
Balance at Jun. 30, 2023 9,976,559     $ 181 $ 0 14,418,946 (60,275) (4,382,293)
Beginning balance (in shares) at Mar. 31, 2023       176,121,918 9,617,605      
Balance at Mar. 31, 2023 10,318,866     $ 174 $ 12 14,233,590 (71,945) (3,842,965)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (166,187)             (166,187)
Exercises of vested stock options (in shares)       33,438 30,783      
Exercises of vested stock options 1,477         1,477    
Vesting of restricted stock units (in shares)       1,144,112        
Vesting of restricted stock units 0     $ 1   (1)    
Value of equity awards withheld for tax liability (in shares)       (872)        
Value of equity awards withheld for tax liability (53)         (53)    
Conversion of shares of Class B common stock into shares of Class A common stock (in shares)       9,648,388 (9,648,388)      
Conversion of shares of Class B common stock into shares of Class A common stock 0     $ 12 $ (12)      
Shares issued under ESPP (in shares)       579,857        
Shares issued under ESPP 23,337         23,337    
Shares of Class A common stock issued and donated to charity (in shares)       22,102        
Shares of Class A common stock issued and donated to charity 1,047         1,047    
Unrealized gain (loss) on marketable securities $ 8,605           8,605  
Repurchases of shares of Class A common stock including related costs (in shares) (6,400,000)     (6,374,327)        
Repurchases of shares of Class A common stock including related costs $ (373,147)     $ (6)       (373,141)
Foreign currency translation 86           86  
Net change in market value of effective foreign currency forward exchange contracts (2,167)           (2,167)  
Share of other comprehensive income from equity method investment 5,146           5,146  
Stock-based compensation 159,253         159,253    
Stock-based compensation - restructuring 296         296    
Ending balance (in shares) at Jun. 30, 2023   181,174,616 0 181,174,616 0      
Balance at Jun. 30, 2023 $ 9,976,559     $ 181 $ 0 $ 14,418,946 $ (60,275) $ (4,382,293)